Unanticipated demyelinating pathology of the CNS

Nature Reviews Neurology

Volumn 5, Issue 11, 2009, Pages 591-597

  Okuda, Darin T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPSY; CADAVER; CENTRAL NERVOUS SYSTEM DISEASE; COGNITIVE DEFECT; DEMYELINATING DISEASE; DISEASE CLASSIFICATION; DISEASE COURSE; DIZYGOTIC TWINS; FAMILY HISTORY; HISTOPATHOLOGY; HUMAN; MONOZYGOTIC TWINS; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

AUTOPSY; CENTRAL NERVOUS SYSTEM; COHORT STUDIES; DEMYELINATING DISEASES; DISEASE PROGRESSION; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS;

EID: 70449520448     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2009.157     Document Type: Review

References (34)

1. Vernooij, M. W. et al. Incidental findings on brain MRI in the general population. N. Engl. J. Med. 357, 1821-1828 (2007).
2. Weber, F. & Knopf, H. Incidental findings in magnetic resonance imaging of the brains of healthy young men. J. Neurol. Sci. 240, 81-84 (2006).
3. Okuda, D. T. et al. Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome. Neurology 72, 800-805 (2009).
4. Lebrun, C. et al. Unexpected multiple sclerosis: Follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile. J. Neurol. Neurosurg. Psychiatry 79, 195-198 (2008).
5. Miller, D. H. et al. Differential diagnosis of suspected multiple sclerosis: A consensus approach. Mult. Scler. 14, 1157-1174 (2008).
6. Miller, D. H. et al. Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis. Ann. Neurol. 56, 273-278 (2004).
7. Courville, C. B. Multiple sclerosis as an incidental complication of a disorder of lipid metabolism. I. Close resemblance of the lesions resulting from fat embolism to the plaques of multiple sclerosis. Bull. Los Angel. Neuro. Soc. 24, 60-76 (1959).
8. Georgi, W. Multiple sclerosis. Anatomopathological findings of multiple sclerosis in diseases not clinically diagnosed [German]. Schweiz. Med. Wochenschr. 91, 605-607 (1961).
9. Gilbert, J. J. & Sadler, M. Unsuspected multiple sclerosis. Arch. Neurol. 40, 533-536 (1983).
10. Engell, T. A clinical patho-anatomical study of clinically silent multiple sclerosis. Acta Neurol. Scand. 79, 428-430 (1989).
11. Mackay, R. P. & Hirano, A. Forms of benign multiple sclerosis. Report of two "clinically silent" cases discovered at autopsy. Arch. Neurol. 17, 588-600 (1967).
12. Morariu, M. & Klutzow, W. F. Subclinical multiple sclerosis. J. Neurol. 213, 71-76 (1976).
13. Phadke, J. G. & Best, P. V. Atypical and clinically silent multiple sclerosis: A report of 12 cases discovered unexpectedly at necropsy. J. Neurol. Neurosurg. Psychiatry 46, 414-420 (1983).
14. Barkhof, F. et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120, 2059-2069 (1997).
15. Compston, A. & Coles, A. Multiple sclerosis. Lancet 359, 1221-1231 (2002).
16. McFarland, H. F. et al. Studies of multiple sclerosis in twins, using nuclear magnetic resonance. Neurology 35 (Suppl. 1), 137 (1985).
17. Ebers, G. C. et al. A population-based study of multiple sclerosis in twins. N. Engl. J. Med. 315, 1638-1642 (1986).
18. Kinnunen, E. et al. Genetic susceptibility to multiple sclerosis. A co-twin study of a nationwide series. Arch. Neurol. 45, 1108-1111 (1988).
19. Lynch, S. G., Rose, J. W., Smoker, W. & Petajan, J. H. MRI in familial multiple sclerosis. Neurology 40, 900-903 (1990).
20. Tienari, P. J., Salonen, O., Wikstrom, J., Valanne, L. & Palo, J. Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings. J. Neurol. Neurosurg. Psychiatry 55, 883-886 (1992).
21. [No authors listed] Multiple sclerosis in 54 twinships: Concordance rate is independent of zygosity. French Research Group on Multiple Sclerosis. Ann. Neurol. 32, 724-727 (1992).
22. Paty, D. W. et al. MRI in the diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38, 180-185 (1988).
23. Sadovnick, A. D. et al. A population-based study of multiple sclerosis in twins: Update. Ann. Neurol. 33, 281-285 (1993).
24. Fazekas, F. et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 38, 1822-1825 (1988).
25. Thorpe, J. W. et al. British Isles survey of multiple sclerosis in twins: MRI. J. Neurol. Neurosurg. Psychiatry 57, 491-496 (1994).
26. De Stefano, N. et al. Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosis. Ann. Neurol. 59, 634-639 (2006).
27. McDonnell, G. V., Cabrera-Gomez, J., Calne, D. B., Li, D. K. & Oger, J. Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: The subclinical stage of primary progressive multiple sclerosis may last 10 years. Mult. Scler. 9, 204-209 (2003).
28. Tintore, M. et al. Isolated demyelinating syndromes: Comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am. J. Neuroradiol. 21, 702-706 (2000).
29. Lebrun, C. et al. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients. Arch. Neurol. 66, 841-846 (2009).
30. Sadovnick, A. D. et al. Factors influencing sib risks for multiple sclerosis. Clin. Genet. 58, 431-435 (2000).
31. Fisniku, L. K. et al. Disability and T2 MRI lesions: A 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 131, 808-817 (2008).
32. Goodin, D. S. Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: Have we been overly harsh in our assessment? Ann. Neurol. 59, 597-605 (2006).
33. De Groot, C. J. et al. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: Increased yield of active demyelinating and (p) reactive lesions. Brain 124, 1635-1645 (2001).
34. Trapp, B. D. et al. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338, 278-285 (1998).